2,3-Fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals
US9604954B2 · kind B2 · utility
0Cited by
6References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2015 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | Nov 19, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having a structure of Formula I and compositions comprising these compounds are provided. Uses of such compounds and compositions are provided for treatment or prophylaxis of viral infection. In particular, compounds and compositions may be for use in the treatment or prophylaxis of viral influenza.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.